<body><div id="content_start"></div> <article class="j-blog"><div class="n j-blog-meta j-blog-post--header"> <div class="j-text j-module n"> <span class="j-text j-blog-post--date"> 04. May 2016 </span> </div> <h1 class="j-blog-header j-blog-headline j-blog-post--headline"></h1></div><div class="post j-blog-content"> <div id="cc-matrix-2846884298"><div id="cc-m-10526055098" class="j-module n j-downloadDocument "> <a class="j-m-dowload" href="https://www.pharmaexcipients.com/wp-content/uploads/attachments/Hughes+-+EU+GMP+Risk+Assessment+fo+Excipients.pdf?t=1462340438" onclick="_gaq.push(['a._trackPageview', 'https://www.pharmaexcipients.com/wp-content/uploads/attachments/Hughes+-+EU+GMP+Risk+Assessment+fo+Excipients.pdf']);"> <img src="https://www.pharmaexcipients.com/wp-content/uploads/2018/08/pdf.png" width="51" height="51" class="downloadImage" alt="Download"> </a> <div data-name="download-description" class="descriptionContainer"> <div class="cc-m-download-title"></div> <div class="cc-m-download-description">Kevin Hughes<br>Regulatory Affairs Manager, Colorcon Ltd<br>Making Pharmaceuticals 2016</div> <div class="cc-m-download-file"> <div class="cc-m-download-file-name">Hughes - EU GMP Risk Assessment fo Excip</div> <div class="cc-m-download-file-info"> <span class="cc-m-download-file-type">Adobe Acrobat Document</span> <span class="cc-m-download-file-size">892.0 KB</span> </div> <div class="cc-m-download-file-link"><a href="https://www.pharmaexcipients.com/wp-content/uploads/attachments/Hughes+-+EU+GMP+Risk+Assessment+fo+Excipients.pdf?t=1462340438" onclick="_gaq.push(['a._trackPageview', 'https://www.pharmaexcipients.com/wp-content/uploads/attachments/Hughes+-+EU+GMP+Risk+Assessment+fo+Excipients.pdf']);" class="cc-m-download-link">Download</a></div> </div> </div> </div></div> </div><div class="n" id="flexsocialbuttons"><div class="cc-sharebuttons-element cc-sharebuttons-size-32 cc-sharebuttons-style-colored cc-sharebuttons-design-round cc-sharebuttons-align-left"> <a class="cc-sharebuttons-googleplus" href="https://plus.google.com/share?url=https://www.pharma-excipients.ch/2016/05/04/gmp-aspects-of-excipient-supplya-risk-based-approach/" title="Google+" target="_blank" rel="noopener"></a><a class="cc-sharebuttons-mail" href="mailto:?subject=GMP%20Aspects%20of%20Excipient%20Supply%20a%20risk%20based%20approach&body=https://www.pharma-excipients.ch/2016/05/04/gmp-aspects-of-excipient-supplya-risk-based-approach/" title="Email" target="" rel="noopener"></a><a class="cc-sharebuttons-linkedin" href="http://www.linkedin.com/shareArticle?mini=true&url=https://www.pharma-excipients.ch/2016/05/04/gmp-aspects-of-excipient-supplya-risk-based-approach/&title=GMP%20Aspects%20of%20Excipient%20Supply%20a%20risk%20based%20approach" title="LinkedIn" target="_blank" rel="noopener"></a><a class="cc-sharebuttons-xing" href="https://www.xing.com/social_plugins/share/new?url=https://www.pharma-excipients.ch/2016/05/04/gmp-aspects-of-excipient-supplya-risk-based-approach/" title="Xing" target="_blank" rel="noopener"></a><a class="cc-sharebuttons-tumblr" href="http://www.tumblr.com/share?v=3&u=https://www.pharma-excipients.ch/2016/05/04/gmp-aspects-of-excipient-supplya-risk-based-approach/&t=GMP%20Aspects%20of%20Excipient%20Supply%20a%20risk%20based%20approach" title="Tumblr" target="_blank" rel="noopener"></a></div></div></article> </body>